Suppr超能文献

抑郁症患者注射促肾上腺皮质激素释放激素后促肾上腺皮质激素的释放与地塞米松抑制试验的关系

Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.

作者信息

Thalén B E, Kjellman B F, Ljunggren J G, Akner G, Kågedal B, Wahlund B, Wetterberg L

机构信息

Department of Psychiatry, St. Göran's Hospital, Stockholm, Sweden.

出版信息

Acta Psychiatr Scand. 1993 Feb;87(2):133-40. doi: 10.1111/j.1600-0447.1993.tb03344.x.

Abstract

The possible hypersecretion involvement of corticotropin-releasing hormone (CRH) in the pathophysiology of hypothalamic-pituitary-adrenocortical axis disturbances in patients with major depressive episode and with an abnormal dexamethasone suppression test (DST) was investigated. The corticotropin (ACTH) and cortisol response to the injection of 45 micrograms of synthetic human CRH at 1630 were analyzed in 24 inpatients with normal (suppressors) or abnormal (nonsuppressors) DST. The outcome of the DST was analyzed using 3 cut-off points for the cortisol levels. The clinical assessments included two rating scales. The results showed that nonsuppressors had a significantly lower ACTH response to CRH stimulation than suppressors at all cut-off points (calculated as net area under the curve and as the difference between the peak and the baseline level) despite no significant differences in the severity of depression.

摘要

研究了促肾上腺皮质激素释放激素(CRH)的可能分泌过多在重度抑郁发作且地塞米松抑制试验(DST)异常的患者下丘脑-垂体-肾上腺皮质轴功能紊乱病理生理学中的作用。对24例地塞米松抑制试验正常(抑制者)或异常(非抑制者)的住院患者,分析了16:30注射45微克合成人促肾上腺皮质激素释放激素后促肾上腺皮质激素(ACTH)和皮质醇的反应。使用皮质醇水平的3个临界点分析地塞米松抑制试验的结果。临床评估包括两个评定量表。结果显示,尽管抑郁严重程度无显著差异,但在所有临界点(以曲线下净面积以及峰值与基线水平之差计算),非抑制者对促肾上腺皮质激素释放激素刺激的促肾上腺皮质激素反应均显著低于抑制者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验